Search Lavipharm.com

 

2018

  Peania, February 9th, 2018 - Lavipharm S.A., pursuant to Article 19 of European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that on 07.02.2018, T & A Holdings (Luxembourg) sarl, a company related to Lavipharm SA's Executive Chairman, Mr....

  Peania, June 15th, 2018 - The Ordinary Annual Shareholders Meeting of Lavipharm SA took place on Friday, June 15th, at the company's headquarters in Peania, with a 54.48% quorum. During the Shareholders’ Meeting, the management team presented all topics of the agenda along with the Annual...

  Peania, June 29th 2018 - Lavipharm S.A., pursuant to Article 19 of European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that on 28.06.2018, T & A Holdings (Luxembourg) sarl, a company related to Lavipharm SA's Executive Chairman, Mr....

  Paiania, September 28, 2018 – Lavipharm demonstrated a solid performance in the first half of 2018. Despite the significant increase of obligatory rebates and clawbacks that burdened the pharma industry, Lavipharm sustained its Turnover and profitability, both at a consolidated and at parent company levels. More...

  Peania, October 24th 2018 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that T & A Holdings (Luxembourg) sarl, a company related to Lavipharm SA's Executive Chairman, Mr. Athanasios...

  Peania, December 6th 2018 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, on December 3rd, 2018, T & A Holdings (Luxembourg) sarl, a company related to Lavipharm SA's...